Concepedia

Holly A. Bina

HA

Statistics

Publications

16

Citations

4.4K

H-Index

16

Active since

2007

Affiliations

Eli Lilly (United States)(Current)

Beth Israel Deaconess Medical Center

Harvard University

Karolinska University Hospital

Holly A. Bina is an author at Eli Lilly (United States) specializing in life sciences, fibroblast growth factor 21 signaling, and metabolic regulation.

Publications per year

2007–2019

16

Publications

16

Fibroblast Growth Factor 21 Corrects Obesity in Mice

Tamer Coşkun, Holly A. Bina, M. Schneider et al. · Endocrinology · 2008 · 1K citations

, , +17

Obesity Is a Fibroblast Growth Factor 21 (FGF21)-Resistant State

Ffolliott M. Fisher, Patricia C. Chui, Patrick J. Antonellis et al. · Diabetes · 2010 · 822 citations · Full text

, , +17

The Circulating Metabolic Regulator FGF21 Is Induced by Prolonged Fasting and PPARα Activation in Man

Cecilia Gälman, Tomas Lundåsen, Alexei Kharitonenkov et al. · Cell Metabolism · 2008 · 501 citations · Full text

, , +14

FGF21 is an Akt‐regulated myokine

Yasuhiro Izumiya, Holly A. Bina, Noriyuki Ouchi et al. · FEBS Letters · 2008 · 414 citations

, , +13

FGF‐21/FGF‐21 receptor interaction and activation is determined by βKlotho

Alexei Kharitonenkov, James D. Dunbar, Holly A. Bina et al. · Journal of Cellular Physiology · 2007 · 320 citations

, , +14

1–5 of 16